1. Home
  2. Companies
  3. ATH
  4. Key People

Alterity Therapeutics (ASX:ATH) - Key People

ASX:ATH · Directors, executives and key personnel · 12 month lookback

David A. Stamler, M.D. Current
CEO

No articles mention this person in the last 12 months.

Dr David Stamler Current
Managing Director & Chief Executive Officer
Mentioned in
Healthcare Wrap - Week 28 (6 July -> 10 July) 2026
11 July 2026
FDA Confirms Single Phase 3 Trial Pathway for Alterity’s ATH434 in MSA
7 July 2026
Market Wrap - Week 24 (8 June -> 12 June) 2026
13 June 2026
Healthcare Wrap - Week 24 (8 June -> 12 June) 2026
13 June 2026
+20 more articles →

Also Mentioned

People named in Alterity Therapeutics (ASX:ATH) articles over the last 12 months, by frequency.

Daniel Claassen · 11 articles Geoffrey Kempler · 4 articles Brian Meltzer · 4 articles Remy Bernarda · 3 articles Abby Macnish Niven · 3 articles Paula Trujillo · 2 articles Ann Cunningh · 2 articles Roy Freeman · 2 articles Julian Babarczy · 2 articles Tara Speranza · 2 articles Casey McDonald · 2 articles Julian Barbaczy · 1 article Lawrence Gozlan · 1 article Peter Marks · 1 article Colin Masters · 1 article Nadia Stefanova · 1 article Millie Macdonald · 1 article Ana Luiza Harrop · 1 article